*Following a 90-day Diabetes care management program in 366 subjects with type 2 Diabetes, average baseline HbA1c: 11.2%. † A Diabetes Care Management Program for uncontrolled type 2 Diabetes in a predominantly African American population amortized over the study cohort due to reduced risk of all factors hospitalization after 90 days compared to usual care. ‡ In a study (n=141) using the Philips Connected Blood Glucose Monitor combined with a disease management call center over a 2-year period. § Through patient participation in post-acute and readmission-prevention programs.
References: 1. Magee MF, Baker KM, Fernandez SJ, et al. Redesigning ambulatory care management for uncontrolled type 2 diabetes: a prospective cohort study of the impact of a Boot Camp model on outcomes. BMJ Open Diabetes Res Care. 2019;7(1):e000731. doi:10.1136/bmjdrc-2019-000731 2. Javitt JC, Reese CS, Derrick MK. Deployment of an mHealth patient monitoring solution for diabetes—improved glucose monitoring leads to reduction in medical expenditure. US Endocrinology. 2013;9(2):119-123. doi:10.17925/USE.2013.09.02.119 3. Data on file. 4. Wallace EL, Rosner MH, Alscher MD, et al. Remote patient management for home dialysis patients. Kidney Int Rep. 2017;2(6):1009-1017. doi:10.1016/j.ekir.2017.07.010 References: 5. Benzo R, Hoult J, McEvoy C, et al. Promoting chronic obstructive pulmonary disease wellness through remote monitoring and health coaching: a clinical trial. Ann Am Thorac Soc. 2022;19(11):1808–1817. doi:10.1513/AnnalsATS.202203-214OC 6. Isaranuwatchai W, Redwood O, Schauer A, Van Meer T, Vallée J, Clifford P. A remote patient monitoring intervention for patients with chronic obstructive pulmonary disease and chronic heart failure: pre-post economic analysis of the Smart Program. JMIR Cardio. 2018;2(2):e10319. doi:10.2196/10319